At the vet - itchy dog steps and treatments

Steps taken to determine the cause of an itch
Step 1 - Rule out parasites
Step 2 - Treat skin infections
Step 3 - Conduct a food trial
Step 4 - Confirm atopic dermatitis

What treatments are available for an itchy dog?
The good news is that Zoetis has brought new products to the market. Speak to your vet about these new treatments.
A new monthly injectable product containing a monoclonal antibody for the treatment of atopic dogs
- Providing fast and effective relief of itch2
- Improving the lives of dogs and their owners2
- Can be used in dogs over 12 months of age weighing 3 kg in body weight and over
- Not to be used in pregnant, lactating or breeding dogs
Your dog can enjoy a greater quality of life because of the immediate relief of itch and inflammation associated with these amazing new products on the market.
References
- H. Moyaert et al. A three month, blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client owned dogs with atopic dermatitis. © 2017 ESVD and ACVD, Veterinary Dermatology, 28, 533–553.
- Clinician’s Forum, Understanding Apoquel & Dispelling the Myths. Expert Views from a Roundtable on Apoquel.
Product Legals
For animal use only.
SIMPARICA 5 mg (chewable tablets for dogs). Reg. No.: G4317 (Act 36/1947). Each chewable tablet contains 5 mg sarolaner.
SIMPARICA 10 mg (chewable tablets for dogs). Reg. No.: G4322 (Act 36/1947). Each chewable tablet contains 10 mg sarolaner.
SIMPARICA 20 mg (chewable tablets for dogs). Reg. No.: G4318 (Act 36/1947). Each chewable tablet contains 20 mg sarolaner.
SIMPARICA 40 mg (chewable tablets for dogs). Reg. No.: G4319 (Act 36/1947). Each chewable tablet contains 40 mg sarolaner.
SIMPARICA 80 mg (chewable tablets for dogs). Reg. No.: G4320 (Act 36/1947). Each chewable tablet contains 80 mg sarolaner.
SIMPARICA 120 mg (chewable tablets for dogs). Reg. No.: G4321 (Act 36/1947). Each chewable tablet contains 120 mg sarolaner.
For “WARNINGS” refer to the approved package insert. For full prescribing information refer to the package insert approved by the medicines regulatory authority.